159 related articles for article (PubMed ID: 12820149)
1. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and beta-methyldigoxin in rats.
Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
J Pharm Sci; 2003 Jul; 92(7):1455-63. PubMed ID: 12820149
[TBL] [Abstract][Full Text] [Related]
2. Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and beta-methyldigoxin in rats.
Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
J Pharm Sci; 2005 Jun; 94(6):1196-203. PubMed ID: 15858844
[TBL] [Abstract][Full Text] [Related]
3. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
[TBL] [Abstract][Full Text] [Related]
4. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.
Pauli-Magnus C; Mürdter T; Godel A; Mettang T; Eichelbaum M; Klotz U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):337-43. PubMed ID: 11284449
[TBL] [Abstract][Full Text] [Related]
7. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
9. Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and in vivo.
Yoshida N; Takagi A; Kitazawa H; Kawakami J; Adachi I
J Pharm Sci; 2006 Mar; 95(3):552-60. PubMed ID: 16419049
[TBL] [Abstract][Full Text] [Related]
10. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
Yigitaslan S; Erol K; Cengelli C
Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
[TBL] [Abstract][Full Text] [Related]
11. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
Su SF; Huang JD
Drug Metab Dispos; 1996 Feb; 24(2):142-7. PubMed ID: 8742224
[TBL] [Abstract][Full Text] [Related]
13. Species differences of inhibitory effects on P-glycoprotein-mediated drug transport.
Suzuyama N; Katoh M; Takeuchi T; Yoshitomi S; Higuchi T; Asashi S; Yokoi T
J Pharm Sci; 2007 Jun; 96(6):1609-18. PubMed ID: 17094122
[TBL] [Abstract][Full Text] [Related]
14. The complexity of intestinal absorption and exsorption of digoxin in rats.
Yao HM; Chiou WL
Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
[TBL] [Abstract][Full Text] [Related]
15. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
16. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
[TBL] [Abstract][Full Text] [Related]
17. Interactions between verapamil and digoxin in Langendorff-perfused rat hearts: the role of inhibition of P-glycoprotein in the heart.
Aylin Arici M; Kilinc E; Demir O; Ates M; Yesilyurt A; Gelal A
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):847-52. PubMed ID: 22545967
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
Rameis H; Bonelli J; Waginger H; Hruby K
Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
[TBL] [Abstract][Full Text] [Related]
19. Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
Neuhoff S; Yeo KR; Barter Z; Jamei M; Turner DB; Rostami-Hodjegan A
J Pharm Sci; 2013 Sep; 102(9):3161-73. PubMed ID: 23686764
[TBL] [Abstract][Full Text] [Related]
20. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
